Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Rilvegostomig
BIOLOGICAL: Volrustomig
BIOLOGICAL: Sabestomig
BIOLOGICAL: Pembrolizumab

Sponsor

Presage Biosciences